|
|
Prepublished online as a Blood First Edition Paper on July 10, 2003; DOI 10.1182/blood-2003-05-1417.

Submitted May 6, 2003
Accepted July 3, 2003
HSP27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers Dexamethasone resistance
Dharminder Chauhan, Guilan Li, Teru Hideshima, Klaus Podar, Constantine Mitsiades, Nicholas Mitsiades, Laurence Catley, Yu Tzu Tai, Toshi Hayashi, Reshma Shringharpure, Renate Burger, Nikhil Munshi, Yasuyuki Ohtake, Satya Saxena, and Kenneth C Anderson*
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA
Department of Oncology, The Jikei University School of Medicine, Tokyo, Japan
Lovelace Respiratory Res. Institute, Alburquerque, NM, USA
* Corresponding author; email: kenneth_anderson{at}dfci.harvard.edu.
Smac, second mitochondria-derived activator of caspases promotes apoptosis via activation of caspases. Heat shock protein-27 (Hsp27) negatively regulates another mitochondrial protein, cytochrome-c during apoptosis; however, the role of Hsp27 in modulating Smac release is unknown. Here we show that Hsp27 is overexpressed in both Dexamethasone (Dex)-resistant multiple myeloma (MM) cell lines (MM.1R, U266, RPMI-8226) and primary patient cells. Blocking Hsp27 by an anti-sense (AS) strategy restores the apoptotic response to Dex in Dex-resistant MM cells via triggering the release of mitochondrial protein Smac, followed by activation of caspase-9 and -3. Moreover, AS-Hsp27 overcomes interleukin-6 (IL-6) mediated protection against Dex-induced apoptosis. These data demonstrate that Hsp27 inhibits the release of Smac, and thereby confers Dex-resistance in MM cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Cervantes-Gomez, R. Nimmanapalli, and V. Gandhi
Transcription Inhibition of Heat Shock Proteins: A Strategy for Combination of 17-Allylamino-17-Demethoxygeldanamycin and Actinomycin D
Cancer Res.,
May 1, 2009;
69(9):
3947 - 3954.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Roccaro, X. Leleu, A. Sacco, X. Jia, M. Melhem, A.-S. Moreau, H. T. Ngo, J. Runnels, A. Azab, F. Azab, et al.
Dual targeting of the proteasome regulates survival and homing in Waldenstrom macroglobulinemia
Blood,
May 1, 2008;
111(9):
4752 - 4763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Wu, H. Kausar, P. Johnson, D. E. Montoya-Durango, M. Merchant, and M. J. Rane
Hsp27 Regulates Akt Activation and Polymorphonuclear Leukocyte Apoptosis by Scaffolding MK2 to Akt Signal Complex
J. Biol. Chem.,
July 27, 2007;
282(30):
21598 - 21608.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Schmitt, M. Gehrmann, M. Brunet, G. Multhoff, and C. Garrido
Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy
J. Leukoc. Biol.,
January 1, 2007;
81(1):
15 - 27.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Wick
The Heat Is on: Heat-Shock Proteins and Atherosclerosis
Circulation,
August 29, 2006;
114(9):
870 - 872.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Martin-Ventura, V. Nicolas, X. Houard, L. M. Blanco-Colio, A. Leclercq, J. Egido, R. Vranckx, J.-B. Michel, and O. Meilhac
Biological Significance of Decreased HSP27 in Human Atherosclerosis
Arterioscler Thromb Vasc Biol,
June 1, 2006;
26(6):
1337 - 1343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yan, P. Frost, Y. Shi, B. Hoang, S. Sharma, M. Fisher, J. Gera, and A. Lichtenstein
Mechanism by Which Mammalian Target of Rapamycin Inhibitors Sensitize Multiple Myeloma Cells to Dexamethasone-Induced Apoptosis
Cancer Res.,
February 15, 2006;
66(4):
2305 - 2313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Thomas, M. L. Sos, T. Zander, O. Mani, A. Popov, D. Berenbrinker, S. Smola-Hess, J. L. Schultze, and J. Wolf
Inhibition of Nuclear Translocation of Nuclear Factor-{kappa}B Despite Lack of Functional I{kappa}B{alpha} Protein Overcomes Multiple Defects in Apoptosis Signaling in Human B-Cell Malignancies
Clin. Cancer Res.,
November 15, 2005;
11(22):
8186 - 8194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Chauhan, G. Li, K. Podar, T. Hideshima, P. Neri, D. He, N. Mitsiades, P. Richardson, Y. Chang, J. Schindler, et al.
A Novel Carbohydrate-Based Therapeutic GCS-100 Overcomes Bortezomib Resistance and Enhances Dexamethasone-Induced Apoptosis in Multiple Myeloma Cells
Cancer Res.,
September 15, 2005;
65(18):
8350 - 8358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hideshima, D. Chauhan, P. Richardson, and K. C. Anderson
Identification and Validation of Novel Therapeutic Targets for Multiple Myeloma
J. Clin. Oncol.,
September 10, 2005;
23(26):
6345 - 6350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Traka, A. V. Gasper, J. A. Smith, C. J. Hawkey, Y. Bao, and R. F. Mithen
Transcriptome Analysis of Human Colon Caco-2 Cells Exposed to Sulforaphane
J. Nutr.,
August 1, 2005;
135(8):
1865 - 1872.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. W. Small, Y. Y. Shi, N. A. Edmund, S. Somasundaram, D. T. Moore, and R. Z. Orlowski
Evidence That Mitogen-Activated Protein Kinase Phosphatase-1 Induction by Proteasome Inhibitors Plays an Antiapoptotic Role
Mol. Pharmacol.,
December 1, 2004;
66(6):
1478 - 1490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Chauhan, G. Li, K. Podar, T. Hideshima, C. Mitsiades, R. Schlossman, N. Munshi, P. Richardson, F. E. Cotter, and K. C. Anderson
Targeting mitochondria to overcome conventional and bortezomib/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cells
Blood,
October 15, 2004;
104(8):
2458 - 2466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Y. Almawi, O. K. Melemedjian, and M. M. A. Jaoude
On the link between Bcl-2 family proteins and glucocorticoid-induced apoptosis
J. Leukoc. Biol.,
July 1, 2004;
76(1):
7 - 14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Beere
`The stress of dying': the role of heat shock proteins in the regulation of apoptosis
J. Cell Sci.,
June 1, 2004;
117(13):
2641 - 2651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Chauhan, G. Li, K. Podar, T. Hideshima, R. Shringarpure, L. Catley, C. Mitsiades, N. Munshi, Y. T. Tai, N. Suh, et al.
The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti-multiple myeloma (MM) activity and overcome bortezomib resistance
Blood,
April 15, 2004;
103(8):
3158 - 3166.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|